US Broker Ratings

Merus N.V. (MRUS) Stock Analysis: Potential Upside in the Biotech Sector

Merus N.V. (NASDAQ: MRUS), a Dutch biotechnology company, is making waves in the healthcare sector with its innovative approach to immuno-oncology therapies. With a strategic focus..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a Remarkable 151% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) presents a compelling opportunity for investors in the biotechnology sector, exhibiting a notable potential upside of 151.22% based on the average..

Vericel Corporation (VCEL) Stock Analysis: Potential 43.79% Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL) stands out in the biotechnology sector with a promising growth trajectory, especially given the company’s focus on innovative cellular therapies and biologic..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 63.60% Potential Upside in the Medical Devices Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, is capturing investor attention with its diagnostic testing solutions. As a key contender in the..

Immunovant, Inc. (IMVT) Stock Analysis: Unpacking a 51% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT) has captured investor attention with a promising 51.19% potential upside, as indicated by analyst target prices. As a clinical-stage immunology company, Immunovant..

Privia Health Group, Inc. (PRVA) Stock Analysis: A Promising 44% Upside for Investors

Privia Health Group, Inc. (NASDAQ: PRVA) stands as a dynamic player in the healthcare sector, specifically within the health information services industry. With a market capitalization..

ImmunityBio, Inc. (IBRX): Harnessing a 407% Revenue Growth with a Promising 28% Upside Potential

ImmunityBio, Inc. (NASDAQ: IBRX), a pioneering player in the biotechnology sector, has been capturing investor attention with its robust revenue growth and promising stock performance. The..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Exploring a 7.68% Potential Upside

For investors considering the healthcare sector, Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents an intriguing opportunity. As a major player in providing behavioral healthcare services across..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Unveiling a 12.8% Potential Upside in Biotech Innovation

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning biotechnology firm based in Switzerland, is making waves in the healthcare sector with its promising portfolio of treatments targeting inflammatory..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Potential 94% Upside Lures Investors

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a biotechnology firm with a focus on rare endocrine diseases, is catching the eye of investors with its significant potential upside...

Arcellx, Inc. (ACLX) Stock Analysis: Navigating Biotech Volatility with Strong Analyst Support

Arcellx, Inc. (NASDAQ: ACLX) is capturing the attention of investors in the biotech sector with its innovative immunotherapy developments. Headquartered in Redwood City, California, Arcellx focuses..

Sotera Health Company (SHC) Stock Analysis: A 16.85% Potential Upside in Healthcare Diagnostics & Research

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $4.97 billion, the..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 50% Upside Potential in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the biotechnology sector with a market capitalization of $4.69 billion, making it an intriguing prospect for investors seeking..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Potential 30.79% Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector, specializes in the development of innovative medical devices, particularly for patients suffering from..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 41.94% Potential Upside Amidst Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL) is drawing significant attention in the biotechnology sector with its promising pipeline and robust analyst support. The clinical-stage biopharmaceutical company, headquartered in..

BrightSpring Health Services (BTSG): Analyst Consensus Reveals Strong Buy Ratings and 8.3% Upside Potential

BrightSpring Health Services, Inc. (BTSG), a formidable player in the U.S. healthcare market, operates within the Health Information Services industry. With a market capitalization of $7.41..

Legend Biotech Corporation (LEGN): Analyst Consensus Highlights 248% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN), a dynamic player in the biotechnology sector, is drawing attention with its significant potential upside of 248.08%, as revealed by recent..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential Amidst 434% Revenue Surge

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing the attention of investors with its remarkable 434% revenue growth, underscoring its potential in the burgeoning biotechnology sector. As..

Sarepta Therapeutics, Inc. (SRPT): Investor Outlook on Promising Gene Therapy Potential and 13.53% Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology sector with its innovative RNA-targeted therapeutics and gene therapies aimed at treating rare diseases..

Viatris Inc. (VTRS) Investor Outlook: Navigating a 3.02% Dividend Yield Amidst Healthcare Opportunities

For individual investors eyeing the healthcare sector, Viatris Inc. (NASDAQ: VTRS) presents an intriguing case. With a market capitalization of $18.38 billion, Viatris operates as a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds